The convergence of fracture repair and stem cells: Interplay of genes, aging, environmental factors and disease

Journal of Bone and Mineral Research

Volumn 29, Issue 11, 2014, Pages 2307-2322

  Hadjiargyrou, Michael ^a   O'Keefe, Regis J ^b  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

aging; animal models; cell tissue signaling; cells of bone; genetically altered mice; injury fracture healing; orthopaedics; paracrine pathways; stem and progenitor cells

Indexed keywords

GROWTH FACTOR; HEAVY METAL; INTEGRIN; MICRORNA;

AGING; BONE REGENERATION; CELL FUNCTION; CELL POPULATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FRACTURE; GENETIC LINKAGE; HEMATOPOIETIC STEM CELL; HUMAN; LIMB REGENERATION; MITOCHONDRION; MORBIDITY; MULTIPOTENT STEM CELL; MUSCLE STEM CELL; NONHUMAN; PERIOSTEUM; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL RESEARCH; TISSUE REGENERATION; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PATHOLOGY; TRANSGENIC MOUSE;

AGING; ANIMALS; BONE REGENERATION; FRACTURES, BONE; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, TRANSGENIC; MICRORNAS; MULTIPOTENT STEM CELLS; SIGNAL TRANSDUCTION;

EID: 84923792299     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2373     Document Type: Review

References (184)

1. Antonova E, Le TK, Burge R, Mershon J., Tibia shaft fractures: costly burden of nonunions. BMC Musculoskelet Disord. 2013; 14: 42.
2. Mabry TM, Prpa B, Haidukewych GJ, Harmsen WS, Berry DJ., Long-term results of total hip arthroplasty for femoral neck fracture nonunion. J Bone Joint Surg Am. 2004; 86-A (10): 2263-7.
3. Frolke JP, Patka P., Definition and classification of fracture non-unions. Injury. 2007; 38 (Suppl 2): S19-22.
4. Ryzewicz M, Morgan SJ, Linford E, Thwing JI, de Resende GV, Smith WR., Central bone grafting for nonunion of fractures of the tibia: a retrospective series. J Bone Joint Surg Br. 2009; 91 (4): 522-9.
5. Lin J., Effectiveness of completely round nails with both-ends-threaded locking screws for tibial shaft fractures. J Trauma. 2006; 61 (4): 893-9.
6. Hadjiargyrou M, Lombardo F, Zhao S, et al., Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J Biol Chem. 2002; 277 (33): 30177-82.
7. Komatsu DE, Warden SJ., The control of fracture healing and its therapeutic targeting: improving upon nature. J Cell Biochem. 2010; 109 (2): 302-11.
8. Matsumoto T, Kuroda R, Mifune Y, et al., Circulating endothelial/skeletal progenitor cells for bone regeneration and healing. Bone. 2008; 43 (3): 434-9.
9. Shah K, Majeed Z, Jonason J, O'Keefe RJ., The role of muscle in bone repair: the cells, signals, and tissue responses to injury. Curr Osteoporos Rep. 2013; 11 (2): 130-5.
10. Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF., Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res. 2008; 26 (2): 165-75.
11. Kuznetsov SA, Mankani MH, Leet AI, Ziran N, Gronthos S, Robey PG., Circulating connective tissue precursors: extreme rarity in humans and chondrogenic potential in guinea pigs. Stem Cells. 2007; 25 (7): 1830-9.
12. Hoogduijn MJ, Verstegen MM, Engela AU, et al., No evidence for circulating mesenchymal stem cells in patients with organ injury. Stem Cells Dev. 2014 Oct 1; 23 (19): 2328-35.
13. Colnot C., Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res. 2009; 24 (2): 274-82.
14. Claes L, Recknagel S, Ignatius A., Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol. 2012; 8 (3): 133-43.
15. Taylor DK, Meganck JA, Terkhorn S, et al., Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing. J Bone Miner Res. 2009; 24 (6): 1043-54.
16. Burke DP, Kelly DJ., Substrate stiffness and oxygen as regulators of stem cell differentiation during skeletal tissue regeneration: a mechanobiological model. PLoS One. 2012; 7 (7): e40737.
17. Komatsu DE, Bosch-Marce M, Semenza GL, Hadjiargyrou M., Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1alpha deficiency. J Bone Miner Res. 2007; 22 (3): 366-74.
18. Komatsu DE, Hadjiargyrou M., Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone. 2004; 34 (4): 680-8.
19. Wan C, Gilbert SR, Wang Y, et al., Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A. 2008; 105 (2): 686-91.
20. Martinez MD, Schmid GJ, McKenzie JA, Ornitz DM, Silva MJ., Healing of non-displaced fractures produced by fatigue loading of the mouse ulna. Bone. 2010; 46 (6): 1604-12.
21. Maes C, Kobayashi T, Selig MK, et al., Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell. 2010; 19 (2): 329-44.
22. Kosaki N, Takaishi H, Kamekura S, et al., Impaired bone fracture healing in matrix metalloproteinase-13 deficient mice. Biochem Biophys Res Commun. 2007; 354 (4): 846-51.
23. Burke D, Dishowitz M, Sweetwyne M, Miedel E, Hankenson KD, Kelly DJ., The role of oxygen as a regulator of stem cell fate during fracture repair in TSP2-null mice. J Orthop Res. 2013; 31 (10): 1585-96.
24. Lu C, Hansen E, Sapozhnikova A, Hu D, Miclau T, Marcucio RS., Effect of age on vascularization during fracture repair. J Orthop Res. 2008; 26 (10): 1384-9.
25. Lu C, Saless N, Wang X, et al., The role of oxygen during fracture healing. Bone. 2013; 52 (1): 220-9.
26. Goessling W, North TE, Loewer S, et al., Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell. 2009; 136 (6): 1136-47.
27. Signer RA, Morrison SJ., Mechanisms that regulate stem cell aging and life span. Cell Stem Cell. 2013; 12 (2): 152-65.
28. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP., Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968; 6 (2): 230-47.
29. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV., Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966; 16 (3): 381-90.
30. Takagi K, Urist MR., The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. Clin Orthop Relat Res. 1982 Nov-Dec; (171): 224-31.
31. Paley D, Young MC, Wiley AM, Fornasier VL, Jackson RW., Percutaneous bone marrow grafting of fractures and bony defects. An experimental study in rabbits. Clin Orthop Relat Res. 1986 Jul; (208): 300-12.
32. Grundel RE, Chapman MW, Yee T, Moore DC., Autogeneic bone marrow and porous biphasic calcium phosphate ceramic for segmental bone defects in the canine ulna. Clin Orthop Relat Res. 1991 May; (266): 244-58.
33. Werntz JR, Lane JM, Burstein AH, Justin R, Klein R, Tomin E., Qualitative and quantitative analysis of orthotopic bone regeneration by marrow. J Orthop Res. 1996; 14 (1): 85-93.
34. Kadiyala S, Young RG, Thiede MA, Bruder SP., Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant. 1997; 6 (2): 125-34.
35. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S., Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res. 1998; 16 (2): 155-62.
36. Connolly JF, Guse R, Tiedeman J, Dehne R., Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res. 1991; (266): 259-70.
37. Garg NK, Gaur S, Sharma S., Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture. Acta Orthop Scand. 1993; 64 (6): 671-2.
38. Sim R, Liang TS, Tay BK., Autologous marrow injection in the treatment of delayed and non-union in long bones. Singapore Med J. 1993; 34 (5): 412-7.
39. Cuomo AV, Virk M, Petrigliano F, Morgan EF, Lieberman JR., Mesenchymal stem cell concentration and bone repair: potential pitfalls from bench to bedside. J Bone Joint Surg Am. 2009; 91 (5): 1073-83.
40. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG., Circulating skeletal stem cells. J Cell Biol. 2001; 153 (5): 1133-40.
41. Kumar S, Ponnazhagan S., Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect. Bone. 2012; 50 (4): 1012-8.
42. Toupadakis CA, Granick JL, Sagy M, et al., Mobilization of endogenous stem cell populations enhances fracture healing in a murine femoral fracture model. Cytotherapy. 2013; 15 (9): 1136-47.
43. Lee SW, Padmanabhan P, Ray P, et al., Stem cell-mediated accelerated bone healing observed with in vivo molecular and small animal imaging technologies in a model of skeletal injury. J Orthop Res. 2009; 27 (3): 295-302.
44. Kumar S, Wan C, Ramaswamy G, Clemens TL, Ponnazhagan S., Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. Mol Ther. 2010; 18 (5): 1026-34.
45. Granero-Molto F, Weis JA, Miga MI, et al., Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells. 2009; 27 (8): 1887-98.
46. Atesok K, Li R, Stewart DJ, Schemitsch EH., Endothelial progenitor cells promote fracture healing in a segmental bone defect model. J Orthop Res. 2010; 28 (8): 1007-14.
47. Levi B, James AW, Nelson ER, et al., Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS One. 2010; 5 (6): e11177.
48. Wosczyna MN, Biswas AA, Cogswell CA, Goldhamer DJ., Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification. J Bone Miner Res. 2012; 27 (5): 1004-7.
49. Cerletti M, Jurga S, Witczak CA, et al., Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell. 2008; 134 (1): 37-47.
50. Tedesco FS, Dellavalle A, Diaz-Manera J, Messina G, Cossu G., Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest. 2010; 120 (1): 11-9.
51. Clever JL, Sakai Y, Wang RA, Schneider DB., Inefficient skeletal muscle repair in inhibitor of differentiation knockout mice suggests a crucial role for BMP signaling during adult muscle regeneration. Am J Physiol Cell Physiol. 2010; 298 (5): C1087-99.
52. Daughters RS, Chen Y, Slack JM., Origin of muscle satellite cells in the Xenopus embryo. Development. 2011; 138 (5): 821-30.
53. Chakkalakal JV, Jones KM, Basson MA, Brack AS., The aged niche disrupts muscle stem cell quiescence. Nature. 2012; 490 (7420): 355-60.
54. Li M, Izpisua Belmonte JC., Ageing: genetic rejuvenation of old muscle. Nature. 2014; 506 (7488): 304-5.
55. Sinha M, Jang YC, Oh J, et al., Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science. 2014; 344 (6184): 649-52.
56. Mourikis P, Gopalakrishnan S, Sambasivan R, Tajbakhsh S., Cell-autonomous Notch activity maintains the temporal specification potential of skeletal muscle stem cells. Development. 2012; 139 (24): 4536-48.
57. Liu R, Schindeler A, Little DG., The potential role of muscle in bone repair. J Musculoskelet Neuronal Interact. 2010; 10 (1): 71-6.
58. Tachi K, Takami M, Sato H, et al., Enhancement of bone morphogenetic protein-2-induced ectopic bone formation by transforming growth factor-beta1. Tissue Eng Part A. 2011; 17 (5-6): 597-606.
59. Liu R, Birke O, Morse A, et al., Myogenic progenitors contribute to open but not closed fracture repair. BMC Musculoskelet Disord. 2011; 12: 288.
60. Yukata K, Xie C, Li TF, et al., Aging periosteal progenitor cells have reduced regenerative responsiveness to bone injury and to the anabolic actions of PTH1-3. treatment. Bone. 2014; 62: 79-89.
61. Matthews BG, Grcevic D, Wang L, et al., Analysis of αSMA-labeled progenitor cell commitment identifies Notch signaling as an important pathway in fracture healing. J Bone Miner Res. 2014; 29 (5): 1283-94.
62. Zhang X, Xie C, Lin AS, et al., Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res. 2005; 20 (12): 2124-37.
63. Nicholls F, Janic K, Filomeno P, Willett T, Grynpas M, Ferguson P., Effects of radiation and surgery on healing of femoral fractures in a rat model. J Orthop Res. 2013; 31 (8): 1323-31.
64. Fukui T, Ii M, Shoji T, et al., Therapeutic effect of local administration of low-dose simvastatin-conjugated gelatin hydrogel for fracture healing. J Bone Miner Res. 2012; 27 (5): 1118-31.
65. Wang Q, Huang C, Zeng F, Xue M, Zhang X., Activation of the Hh pathway in periosteum-derived mesenchymal stem cells induces bone formation in vivo: implication for postnatal bone repair. Am J Pathol. 2010; 177 (6): 3100-11.
66. Minear S, Leucht P, Miller S, Helms JA., rBMP represses Wnt signaling and influences skeletal progenitor cell fate specification during bone repair. J Bone Miner Res. 2010; 25 (6): 1196-207.
67. Tsuji K, Bandyopadhyay A, Harfe BD, et al., BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet. 2006; 38 (12): 1424-9.
68. Hoffman MD, Xie C, Zhang X, Benoit DS., The effect of mesenchymal stem cells delivered via hydrogel-based tissue engineered periosteum on bone allograft healing. Biomaterials. 2013; 34 (35): 8887-98.
69. Zhao L, Zhao J, Wang S, Wang J, Liu J., Comparative study between tissue-engineered periosteum and structural allograft in rabbit critical-sized radial defect model. J Biomed Mater Res B Appl Biomater. 2011; 97 (1): 1-9.
70. Gerstenfeld LC, Cho TJ, Kon T, et al., Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues Organs. 2001; 169 (3): 285-94.
71. Xie C, Ming X, Wang Q, et al., COX-2 from the injury milieu is critical for the initiation of periosteal progenitor cell mediated bone healing. Bone. 2008; 43 (6): 1075-83.
72. -/- mice via activation of prostaglandin E2 receptor subtype 4. Am J Pathol. 2009; 175 (2): 772-85.
73. Sugimoto Y, Narumiya S., Prostaglandin E receptors. J Biol Chem. 2007; 282 (16): 11613-7.
74. Naik AA, Xie C, Zuscik MJ, et al., Reduced COX-2 expression in aged mice is associated with impaired fracture healing. J Bone Miner Res. 2009; 24 (2): 251-64.
75. Zhang M, Ho HC, Sheu TJ, et al., EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair. J Bone Miner Res. 2011; 26 (4): 792-802.
76. Tsuji K, Cox K, Bandyopadhyay A, Harfe BD, Tabin CJ, Rosen V., BMP4 is dispensable for skeletogenesis and fracture-healing in the limb. J Bone Joint Surg Am. 2008; 90 (Suppl 1): 14-8.
77. Tsuji K, Cox K, Gamer L, Graf D, Economides A, Rosen V., Conditional deletion of BMP7 from the limb skeleton does not affect bone formation or fracture repair. J Orthop Res. 2010; 28 (3): 384-9.
78. Govender S, Csimma C, Genant HK, et al., BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002; 84-A (12): 2123-34.
79. Secreto FJ, Hoeppner LH, Westendorf JJ., Wnt signaling during fracture repair. Curr Osteoporos Rep. 2009; 7 (2): 64-9.
80. Zhong N, Gersch RP, Hadjiargyrou M., Wnt signaling activation during bone regeneration and the role of Dishevelled in chondrocyte proliferation and differentiation. Bone. 2006; 39 (1): 5-16.
81. Leucht P, Kim JB, Helms JA., Beta-catenin-dependent Wnt signaling in mandibular bone regeneration. J Bone Joint Surg Am. 2008; 90 (Suppl 1): 3-8.
82. Huang Y, Zhang X, Du K, et al., Inhibition of beta-catenin signaling in chondrocytes induces delayed fracture healing in mice. J Orthop Res. 2012; 30 (2): 304-10.
83. Komatsu DE, Mary MN, Schroeder RJ, Robling AG, Turner CH, Warden SJ., Modulation of Wnt signaling influences fracture repair. J Orthop Res. 2010; 28 (7): 928-36.
84. McGee-Lawrence ME, Ryan ZC, Carpio LR, Kakar S, Westendorf JJ, Kumar R., Sclerostin deficient mice rapidly heal bone defects by activating beta-catenin and increasing intramembranous ossification. Biochem Biophys Res Commun. 2013; 441 (4): 886-90.
85. Arioka M, Takahashi-Yanaga F, Sasaki M, et al., Acceleration of bone development and regeneration through the Wnt/beta-catenin signaling pathway in mice heterozygously deficient for GSK-3beta. Biochem Biophys Res Commun. 2013; 440 (4): 677-82.
86. Minear S, Leucht P, Jiang J, et al., Wnt proteins promote bone regeneration. Sci Transl Med. 2010; 2 (29): 29-30.
87. Gilmour PS, O'Shea PJ, Fagura M, et al., Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats. Toxicol Appl Pharmacol. 2013; 272 (2): 399-407.
88. Ardawi MS, Al-Kadi HA, Rouzi AA, Qari MH., Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res. 2011; 26 (12): 2812-22.
89. Chen Y, Whetstone HC, Lin AC, et al., Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med. 2007; 4 (7): e249.
90. Gaur T, Wixted JJ, Hussain S, et al., Secreted frizzled related protein 1 is a target to improve fracture healing. J Cell Physiol. 2009; 220 (1): 174-81.
91. Shimoaka T, Kamekura S, Chikuda H, et al., Impairment of bone healing by insulin receptor substrate-1 deficiency. J Biol Chem. 2004; 279 (15): 15314-22.
92. Carroll SH, Wigner NA, Kulkarni N, Johnston-Cox H, Gerstenfeld LC, Ravid K., A2B adenosine receptor promotes mesenchymal stem cell differentiation to osteoblasts and bone formation in vivo. J Biol Chem. 2012; 287 (19): 15718-27.
93. Wang L, Quarles LD, Spurney RF., Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PT H(1-34). J Bone Miner Res. 2004; 19 (10): 1661-70.
94. Ekholm E, Hankenson KD, Uusitalo H, et al., Diminished callus size and cartilage synthesis in alpha 1 beta 1 integrin-deficient mice during bone fracture healing. Am J Pathol. 2002; 160 (5): 1779-85.
95. Saeed H, Abdallah BM, Ditzel N, et al., Telomerase-deficient mice exhibit bone loss owing to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment. J Bone Miner Res. 2011; 26 (7): 1494-505.
96. Richardson GD, Breault D, Horrocks G, Cormack S, Hole N, Owens WA., Telomerase expression in the mammalian heart. FASEB J. 2012; 26 (12): 4832-40.
97. Sahin E, Colla S, Liesa M, et al., Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011; 470 (7334): 359-65.
98. Flores I, Blasco MA., The role of telomeres and telomerase in stem cell aging. FEBS Lett. 2010; 584 (17): 3826-30.
99. Sfeir A, de Lange T., Removal of shelterin reveals the telomere end-protection problem. Science. 2012; 336 (6081): 593-7.
100. Martinez P, Blasco MA., Role of shelterin in cancer and aging. Aging Cell. 2010; 9 (5): 653-66.
101. Barefield C, Karlseder J., The BLM helicase contributes to telomere maintenance through processing of late-replicating intermediate structures. Nucleic Acids Res. 2012; 40 (15): 7358-67.
102. Khincha PP, Savage SA., Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol. 2013; 50 (4): 333-47.
103. Savage SA, Giri N, Jessop L, et al., Sequence analysis of the shelterin telomere protection complex genes in dyskeratosis congenita. J Med Genet. 2011; 48 (4): 285-8.
104. Breault DT, Min IM, Carlone DL, et al., Generation of mTert-GFP mice as a model to identify and study tissue progenitor cells. Proc Natl Acad Sci U S A. 2008; 105 (30): 10420-5.
105. Flores I, Canela A, Vera E, Tejera A, Cotsarelis G, Blasco MA., The longest telomeres: a general signature of adult stem cell compartments. Genes Dev. 2008; 22 (5): 654-67.
106. Begus-Nahrmann Y, Lechel A, Obenauf AC, et al., p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. Nat Genet. 2009; 41 (10): 1138-43.
107. Pelicci PG., Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence ? J Clin Invest. 2004; 113 (1): 4-7.
108. Adorno M, Sikandar S, Mitra SS, et al., Usp16 contributes to somatic stem-cell defects in Down's syndrome. Nature. 2013; 501 (7467): 380-4.
109. Choudhury AR, Ju Z, Djojosubroto MW, et al., Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet. 2007; 39 (1): 99-105.
110. Janzen V, Forkert R, Fleming HE, et al., Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature. 2006; 443 (7110): 421-6.
111. Flores I, Blasco MA., A p53-dependent response limits epidermal stem cell functionality and organismal size in mice with short telomeres. PLoS One. 2009; 4 (3): e4934.
112. Anchelin M, Murcia L, Alcaraz-Perez F, Garcia-Navarro EM, Cayuela ML., Behaviour of telomere and telomerase during aging and regeneration in zebrafish. PLoS One. 2011; 6 (2): e16955.
113. Sahin E, Depinho RA., Linking functional decline of telomeres, mitochondria and stem cells during ageing. Nature. 2010; 464 (7288): 520-8.
114. Jiang H, Schiffer E, Song Z, et al., Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease. Proc Natl Acad Sci U S A. 2008; 105 (32): 11299-304.
115. Meyer MH, Meyer RA Jr., Genes with greater up-regulation in the fracture callus of older rats with delayed healing. J Orthop Res. 2007; 25 (4): 488-94.
116. Green E, Lubahn JD, Evans J., Risk factors, treatment, and outcomes associated with nonunion of the midshaft humerus fracture. J Surg Orthop Adv. 2005; 14 (2): 64-72.
117. Gruber R, Koch H, Doll BA, Tegtmeier F, Einhorn TA, Hollinger JO., Fracture healing in the elderly patient. Exp Gerontol. 2006; 41 (11): 1080-93.
118. Leucht P, Jiang J, Cheng D, et al., Wnt3a reestablishes osteogenic capacity to bone grafts from aged animals. J Bone Joint Surg Am. 2013; 95 (14): 1278-88.
119. Mayack SR, Shadrach JL, Kim FS, Wagers AJ., Systemic signals regulate ageing and rejuvenation of blood stem cell niches. Nature. 2010; 463 (7280): 495-500.
120. Doles J, Storer M, Cozzuto L, Roma G, Keyes WM., Age-associated inflammation inhibits epidermal stem cell function. Genes Dev. 2012; 26 (19): 2144-53.
121. Wahl EC, Aronson J, Liu L, et al., Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res. 2010; 25 (1): 114-23.
122. Xing Z, Lu C, Hu D, Miclau T 3rd, Marcucio RS., Rejuvenation of the inflammatory system stimulates fracture repair in aged mice. J Orthop Res. 2010; 28 (8): 1000-6.
123. Oncken C., Nicotine replacement for smoking cessation during pregnancy. N Engl J Med. 2012; 366 (9): 846-7.
124. Goniewicz ML, Hajek P, McRobbie H., Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction. 2014 Mar; 109 (3): 500-7.
125. Benowitz NL, Jacob P 3rd, Herrera B., Nicotine intake and dose response when smoking reduced-nicotine content cigarettes. Clin Pharmacol Ther. 2006; 80 (6): 703-14.
126. Rothem DE, Rothem L, Soudry M, Dahan A, Eliakim R., Nicotine modulates bone metabolism-associated gene expression in osteoblast cells. J Bone Miner Metab. 2009; 27 (5): 555-61.
127. Shen Y, Liu HX, Ying XZ, et al., Dose-dependent effects of nicotine on proliferation and differentiation of human bone marrow stromal cells and the antagonistic action of vitamin C. J Cell Biochem. 2013; 114 (8): 1720-8.
128. Rothem DE, Rothem L, Dahan A, Eliakim R, Soudry M., Nicotinic modulation of gene expression in osteoblast cells. MG-63. Bone. 2011; 48 (4): 903-9.
129. Sato T, Abe T, Nakamoto N, et al., Nicotine induces cell proliferation in association with cyclin D1 up-regulation and inhibits cell differentiation in association with p53 regulation in a murine pre-osteoblastic cell line. Biochem Biophys Res Commun. 2008; 377 (1): 126-30.
130. Yanagita M, Kojima Y, Kawahara T, et al., Suppressive effects of nicotine on the cytodifferentiation of murine periodontal ligament cells. Oral Dis. 2010; 16 (8): 812-7.
131. Ma L, Sham MH, Zheng LW, Cheung LK., Influence of low-dose nicotine on bone healing. J Trauma. 2011; 70 (6): E117-21.
132. Ma L, Zheng LW, Sham MH, Cheung LK., Uncoupled angiogenesis and osteogenesis in nicotine-compromised bone healing. J Bone Miner Res. 2010; 25 (6): 1305-13.
133. Donigan JA, Fredericks DC, Nepola JV, Smucker JD., The effect of transdermal nicotine on fracture healing in a rabbit model. J Orthop Trauma. 2012; 26 (12): 724-7.
134. Martin JW, Mousa SS, Shaker O, Mousa SA., The multiple faces of nicotine and its implications in tissue and wound repair. Exp Dermatol. 2009; 18 (6): 497-505.
135. Hastrup SG, Chen X, Bechtold JE, et al., Effect of nicotine and tobacco administration method on the mechanical properties of healing bone following closed fracture. J Orthop Res. 2010; 28 (9): 1235-9.
136. El-Zawawy HB, Gill CS, Wright RW, Sandell LJ., Smoking delays chondrogenesis in a mouse model of closed tibial fracture healing. J Orthop Res. 2006; 24 (12): 2150-8.
137. Kung MH, Yukata K, O'Keefe RJ, Zuscik MJ., Aryl hydrocarbon receptor-mediated impairment of chondrogenesis and fracture healing by cigarette smoke and benzo(a)pyrene. J Cell Physiol. 2012; 227 (3): 1062-70.
138. Partch CL, Card PB, Amezcua CA, Gardner KH., Molecular basis of coiled coil coactivator recruitment by the aryl hydrocarbon receptor nuclear translocator (ARNT). J Biol Chem. 2009; 284 (22): 15184-92.
139. Cardoso JF, Souza BR, Amadeu TP, Valenca SS, Porto LC, Costa AM., Effects of cigarette smoke in mice wound healing is strain dependent. Toxicol Pathol. 2007; 35 (7): 890-6.
140. Huang J, Okuka M, Lu W, et al., Telomere shortening and DNA damage of embryonic stem cells induced by cigarette smoke. Reprod Toxicol. 2013; 35: 89-95.
141. Huang J, Okuka M, McLean M, Keefe DL, Liu L., Telomere susceptibility to cigarette smoke-induced oxidative damage and chromosomal instability of mouse embryos in vitro. Free Radic Biol Med. 2010; 48 (12): 1663-76.
142. Nawrot T, Geusens P, Nulens TS, Nemery B., Occupational cadmium exposure and calcium excretion, bone density, and osteoporosis in men. J Bone Miner Res. 2010; 25 (6): 1441-5.
143. Madeddu R, Solinas G, Forte G, et al., Diet and nutrients are contributing factors that influence blood cadmium levels. Nutr Res. 2011; 31 (9): 691-7.
144. Engstrom A, Michaelsson K, Suwazono Y, Wolk A, Vahter M, Akesson A., Long-term cadmium exposure and the association with bone mineral density and fractures in a population-based study among women. J Bone Miner Res. 2011; 26 (3): 486-95.
145. Shukla R, Bornschein RL, Dietrich KN, et al., Fetal and infant lead exposure: effects on growth in stature. Pediatrics. 1989; 84 (4): 604-12.
146. Nash D, Magder LS, Sherwin R, Rubin RJ, Silbergeld EK., Bone density-related predictors of blood lead level among peri- and postmenopausal women in the United States: The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2004; 160 (9): 901-11.
147. Beier EE, Maher JR, Sheu TJ, et al., Heavy metal lead exposure, osteoporotic-like phenotype in an animal model, and depression of Wnt signaling. Environ Health Perspect. 2013; 121 (1): 97-104.
148. Carmouche JJ, Puzas JE, Zhang X, et al., Lead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency. Environ Health Perspect. 2005; 113 (6): 749-55.
149. Gaudio A, Privitera F, Battaglia K, et al., Sclerostin levels associated with inhibition of the Wnt/beta-catenin signaling and reduced bone turnover in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012; 97 (10): 3744-50.
150. Manavalan JS, Cremers S, Dempster DW, et al., Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012; 97 (9): 3240-50.
151. Gennari L, Merlotti D, Valenti R, et al., Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab. 2012; 97 (5): 1737-44.
152. Kayal RA, Siqueira M, Alblowi J, et al., TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1. J Bone Miner Res. 2010; 25 (7): 1604-15.
153. Alblowi J, Tian C, Siqueira MF, et al., Chemokine expression is upregulated in chondrocytes in diabetic fracture healing. Bone. 2013; 53 (1): 294-300.
154. Alblowi J, Kayal RA, Siqueira M, et al., High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. Am J Pathol. 2009; 175 (4): 1574-85.
155. Ogasawara A, Nakajima A, Nakajima F, Goto K, Yamazaki M., Molecular basis for affected cartilage formation and bone union in fracture healing of the streptozotocin-induced diabetic rat. Bone. 2008; 43 (5): 832-9.
156. Wu YY, Yu T, Yang XY, et al., Vitamin D3 and insulin combined treatment promotes titanium implant osseointegration in diabetes mellitus rats. Bone. 2013; 52 (1): 1-8.
157. Stolzing A, Sellers D, Llewelyn O, Scutt A., Diabetes induced changes in rat mesenchymal stem cells. Cells Tissues Organs. 2010; 191 (6): 453-65.
158. Rlszer T, Jõzsa T, Kiss-Tõth ED, De Clerck N, Balogh L., Leptin receptor deficient diabetic (db/db) mice are compromised in postnatal bone regeneration. Cell Tissue Res. 2014 Apr; 356 (1): 195-206.
159. Hamann C, Rauner M, Hohna Y, et al., Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus. J Bone Miner Res. 2013; 28 (3): 627-38.
160. Park AG, Paglia DN, Al-Zube L, et al., Local insulin therapy affects fracture healing in a rat model. J Orthop Res. 2013; 31 (5): 776-82.
161. Gandhi A, Beam HA, O'Connor JP, Parsons JR, Lin SS., The effects of local insulin delivery on diabetic fracture healing. Bone. 2005; 37 (4): 482-90.
162. Xu X, Duan S, Yi F, Ocampo A, Liu GH, Izpisua Belmonte JC., Mitochondrial regulation in pluripotent stem cells. Cell Metab. 2013; 18 (3): 325-32.
163. Liu W, Long Q, Chen K, et al., Mitochondrial metabolism transition cooperates with nuclear reprogramming during induced pluripotent stem cell generation. Biochem Biophys Res Commun. 2013; 431 (4): 767-71.
164. Hom JR, Quintanilla RA, Hoffman DL, et al., The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation. Dev Cell. 2011; 21 (3): 469-78.
165. Shyh-Chang N, Daley GQ, Cantley LC., Stem cell metabolism in tissue development and aging. Development. 2013; 140 (12): 2535-47.
166. Suhr ST, Chang EA, Tjong J, et al., Mitochondrial rejuvenation after induced pluripotency. PLoS One. 2010; 5 (11): e14095.
167. Stoll EA, Cheung W, Mikheev AM, et al., Aging neural progenitor cells have decreased mitochondrial content and lower oxidative metabolism. J Biol Chem. 2011; 286 (44): 38592-601.
168. Cerletti M, Jang YC, Finley LW, Haigis MC, Wagers AJ., Short-term calorie restriction enhances skeletal muscle stem cell function. Cell Stem Cell. 2012; 10 (5): 515-9.
169. Munch J, Gonzalez-Rajal A, de la Pompa JL., Notch regulates blastema proliferation and prevents differentiation during adult zebrafish fin regeneration. Development. 2013; 140 (7): 1402-11.
170. Gude N, Sussman M., Notch signaling and cardiac repair. J Mol Cell Cardiol. 2012; 52 (6): 1226-32.
171. Raya A, Koth CM, Buscher D, et al., Activation of Notch signaling pathway precedes heart regeneration in zebrafish. Proc Natl Acad Sci U S A. 2003; 100 (Suppl 1): 11889-95.
172. Basak O, Giachino C, Fiorini E, Macdonald HR, Taylor V., Neurogenic subventricular zone stem/progenitor cells are Notch1-dependent in their active but not quiescent state. J Neurosci. 2012; 32 (16): 5654-66.
173. Dong Y, Jesse AM, Kohn A, et al., RBPjkappa-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development. Development. 2010; 137 (9): 1461-71.
174. Hilton MJ, Tu X, Wu X, et al., Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med. 2008; 14 (3): 306-14.
175. Takeo M, Chou WC, Sun Q, et al., Wnt activation in nail epithelium couples nail growth to digit regeneration. Nature. 2013; 499 (7457): 228-32.
176. Guo L, Zhao RC, Wu Y., The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. Exp Hematol. 2011; 39 (6): 608-16.
177. Fakhry M, Hamade E, Badran B, Buchet R, Magne D., Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. World J Stem Cells. 2013; 5 (4): 136-48.
178. Miyaki S, Sato T, Inoue A, et al., MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev. 2010; 24 (11): 1173-85.
179. Kobayashi T, Lu J, Cobb BS, et al., Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci U S A. 2008; 105 (6): 1949-54.
180. Harfe BD, McManus MT, Mansfield JH, Hornstein E, Tabin CJ., The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci U S A. 2005; 102 (31): 10898-903.
181. Kim KM, Park SJ, Jung SH, et al., miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1. J Bone Miner Res. 2012; 27 (8): 1669-79.
182. Sampson HW, Chaput CD, Brannen J, et al., Alcohol induced epigenetic perturbations during the inflammatory stage of fracture healing. Exp Biol Med (Maywood). 2011; 236 (12): 1389-401.
183. Murata K, Ito H, Yoshitomi H, et al., Inhibition of miR-92a enhances fracture healing via promoting angiogenesis in a model of stabilized fracture in young mice. J Bone Miner Res. 2014; 29 (2): 316-26.
184. Seeliger C, Karpinski K, Haug AT, et al., Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J Bone Miner Res. 2014; 29 (8): 1718-28.